14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.12 $6.38 Friday, 3rd May 2024 CRDF stock ended at $3.52. This is 21.43% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 41.67% from a day low at $3.12 to a day high of $4.42.
90 days $1.44 $6.42
52 weeks $0.94 $6.42

Historical Cardiff Oncology Inc. prices

Date Open High Low Close Volume
May 03, 2024 $3.98 $4.42 $3.12 $3.52 2 135 666
May 02, 2024 $4.25 $4.50 $4.07 $4.48 680 917
May 01, 2024 $4.38 $4.45 $4.15 $4.23 483 846
Apr 30, 2024 $4.50 $4.54 $4.26 $4.36 575 181
Apr 29, 2024 $4.14 $4.68 $4.12 $4.46 1 047 828
Apr 26, 2024 $4.06 $4.13 $3.98 $4.07 482 590
Apr 25, 2024 $4.12 $4.20 $3.95 $3.99 581 014
Apr 24, 2024 $4.17 $4.38 $4.09 $4.18 316 799
Apr 23, 2024 $4.36 $4.42 $4.06 $4.17 699 032
Apr 22, 2024 $4.26 $4.49 $4.25 $4.36 423 816
Apr 19, 2024 $4.38 $4.57 $4.26 $4.35 562 113
Apr 18, 2024 $4.43 $4.48 $4.26 $4.37 826 201
Apr 17, 2024 $4.57 $4.86 $4.32 $4.50 845 497
Apr 16, 2024 $5.62 $5.62 $4.20 $4.59 2 155 744
Apr 15, 2024 $5.62 $5.66 $5.24 $5.28 653 629
Apr 12, 2024 $5.62 $5.86 $5.35 $5.61 823 603
Apr 11, 2024 $5.92 $5.96 $5.57 $5.67 556 822
Apr 10, 2024 $5.55 $5.98 $5.30 $5.89 689 644
Apr 09, 2024 $5.93 $6.27 $5.58 $5.66 939 690
Apr 08, 2024 $6.05 $6.25 $5.56 $5.88 839 680
Apr 05, 2024 $5.90 $6.35 $5.75 $5.84 1 418 909
Apr 04, 2024 $5.46 $6.38 $5.46 $5.67 1 867 956
Apr 03, 2024 $5.40 $5.61 $5.22 $5.33 600 645
Apr 02, 2024 $5.54 $5.61 $5.23 $5.37 613 264
Apr 01, 2024 $5.40 $5.87 $5.20 $5.73 876 581
Click to get the best stock tips daily for free!

About Cardiff Oncology Inc.

Cardiff Oncology. Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac... CRDF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT